Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Studies on enhanced fibrinolytic activity in man.

Literature DB >> 13654517

Studies on enhanced fibrinolytic activity in man.

S SHERRY, R I LINDEMEYER, A P FLETCHER, N ALKJAERSIG.

Abstract

Entities: Species

Keywords: FIBRIN

Mesh：

Substances：
Fibrin

Year: 1959 PMID： 13654517 PMCID： PMC293227 DOI： 10.1172/JCI103863

Source DB: PubMed Journal: J Clin Invest ISSN： 0021-9738 Impact factor: 14.808

× No keyword cloud information.

23 in total

1. A spectrophotometric determination of trypsin and chymotrypsin.

Authors: G W SCHWERT; Y TAKENAKA
Journal: Biochim Biophys Acta Date: 1955-04

2. Activation of plasminogen.

Authors: S MULLERTZ
Journal: Ann N Y Acad Sci Date: 1957-08-30 Impact factor: 5.691

3. Urokinase an activator of plasminogen from human urine. I. Isolation and properties.

Authors: J PLOUG; N O KJELDGAARD
Journal: Biochim Biophys Acta Date: 1957-05

4. On the production of plasma fibrinolytic activity within veins.

Authors: H C KWAAN; R LO; A J MCFADZEAN
Journal: Clin Sci Date: 1957-05 Impact factor: 6.124

5. Evaluation of synthetic substrate methods for clinical determination of fibrinolysis.

Authors: A F LINCOLN; L O MATOUSH; J A MOORMAN; R L SCHULTZ
Journal: Proc Soc Exp Biol Med Date: 1957-01

6. The biological significance of fibrinolysis.

Authors: T ASTRUP
Journal: Lancet Date: 1956-09-15 Impact factor: 79.321

7. Fibrinolytic activity in the circulating blood following amniotic fluid infusion.

Authors: O K ALBRECHTSEN; O STORM; D STROLLE
Journal: Acta Haematol Date: 1955-11 Impact factor: 2.195

8. The fibrinolytic activity of normal blood.

Authors: G R FEARNLEY; R LACKNER
Journal: Br J Haematol Date: 1955-04 Impact factor: 6.998

9. A plasminogen activator in spontaneously active human blood.

Authors: S MULLERTZ
Journal: Proc Soc Exp Biol Med Date: 1953-02

10. Partial purification and properties of a proteolytic enzyme of human serum.

Authors: L F REMMERT; P P COHEN
Journal: J Biol Chem Date: 1949-11 Impact factor: 5.157

51 in total

Review 1. THE FIBRINOLYTIC MECHANISM IN HAEMOSTASIS: A REVIEW.

Authors: J L STAFFORD
Journal: J Clin Pathol Date: 1964-09 Impact factor: 3.411

2. THE EFFECT OF CALCIUM OF FIBRINOLYSIS IN VITRO.

Authors: S BRUCE
Journal: J Clin Pathol Date: 1964-05 Impact factor: 3.411

3. ABNORMAL PLASMINOGEN-PLASMIN SYSTEM ACTIVITY (FIBRINOLYSIS) IN PATIENTS WITH HEPATIC CIRRHOSIS: ITS CAUSE AND CONSEQUENCES.

Authors: A P FLETCHER; O BIEDERMAN; D MOORE; N ALKJAERSIG; S SHERRY
Journal: J Clin Invest Date: 1964-04 Impact factor: 14.808

4. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.

Authors: G P MCNICOL; A S DOUGLAS
Journal: Br Med J Date: 1965-05-01

5. THE USE OF FIBRINOLYTIC ACTIVATORS IN MENINGITIS AND SIMILAR CONDITIONS.

Authors: R L NEWMAN; G T STEWART
Journal: Arch Dis Child Date: 1965-06 Impact factor: 3.791

6. In-vitro and in-vivo studies of a preparation of urokinase.

Authors: G P MCNICOL; S B GALE; A S DOUGLAS
Journal: Br Med J Date: 1963-04-06

7. Thrombolytic therapy.

Authors: G P MCNICOL
Journal: Proc R Soc Med Date: 1963-05

8. Pathogenesis of the coagulation defect developing during pathological plasma proteolytic ("fibrinolytic") states. I. The significance of fibrinogen proteolysis and circulating fibrinogen breakdown products.

Authors: A P FLETCHER; N ALKJAERSIG; S SHERRY
Journal: J Clin Invest Date: 1962-04 Impact factor: 14.808

9. Problems in hemostasis during open-heart surgery. I. On the release of plasminogen activator.

Authors: H GANS; C W LILLEHEI; W KRIVIT
Journal: Ann Surg Date: 1961-12 Impact factor: 12.969

10. The mechanism of clot dissolution by plasmin.

Authors: N ALKJAERSIG; A P FLETCHER; S SHERRY
Journal: J Clin Invest Date: 1959-07 Impact factor: 14.808